Canada has created an initial list of $105B (C$150B) worth of U.S. goods if the incoming Trump administration hits Canadian ...

Calumet shows strong potential as a long-term investment with growth opportunities and positive cash flows. Click here to read why CLMT stock is a Strong Buy.

Jungheinrich's guidance remains steady, though risks persist. Find out why JGHAF stock's valuation suggests upside potential, ...

I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...

Dianthus Therapeutics is advancing treatments for autoimmune diseases. Read why DNTH stock is receiving Buy ratings and price targets of $40 to $58.

Gentex has evolved from smoke detectors to high-tech automotive products, including dimmable glass and full-display mirrors. Read more on the innovations Gentex presented at CES 2025.

Financial writer recommends a soft buy rating on Brunswick Corporation despite recent underperformance. Click for this ...

Vanguard Growth Index Fund ETF Shares thrived in 2024, but economic changes raise concerns. See why we maintain a cautious ...

Datadog, Inc.s strong business and growth prospects are hindered by a steep valuation, making it a risky investment at ...

Palantir is susceptible to a general market decline, as earlier investors cash in on the bubble. Click here to find out why I ...

Quant titan Steven Cress shares his top stocks for 2025, beginning with Celestica (0:45). Intapp's very strong liquidity and ...

Learn why shares have sold off post weak Q3 results. Analysts project EPS growth in FY25 due to stable expenses and lower ...